Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Immunology · India · 2025-11-26

Processing Time
64 days
Decision Date
2025-11-26
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on vaccine development and biotherapeutics addresses critical U.S. public health challenges and national health security.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., NSF funding, and extensive publication and peer-review record demonstrate the capacity to lead this research.

3 Balance of Interests Met

The practical innovations and therapeutic potential of the work justify a waiver of the labor certification requirement in the national interest.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal articles, 2 published abstracts, and 1 book chapter, which garnered 36 citations. Additional evidence included 33 peer reviews for authoritative journals, editorial board membership, and competitive funding from the National Science Foundation (NSF). The case satisfied all three Dhanasar prongs within a processing time of 64 days.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Reference Letters Dependent
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
Tennessee 64 days 2025-03-13
The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 92 days 2023-02-09
The petitioner proposes to continue her research in vaccine development and clinical trial quality control, specifically focusing on how vaccine regimens affect the immune system and the mechanisms regulating vaccine protection. Her work aims to fundamentally transform vaccine development approaches for infectious diseases such as tuberculosis and HIV.
View Case

Postdoctoral Researcher

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
California 489 days 2025-04-22
The petitioner proposes to develop synthetic antibodies with enhanced functional activity against infectious agents, specifically focusing on antibody engineering strategies for conditions like HIV. This work aims to create potent, long-acting solutions for disease prevention and treatment to lower transmission rates and healthcare burdens.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-11-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 64 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist